GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Celgene Corporation (CELG) [hlAlert]

Celgene Corp. is an independent biopharmaceutical company engaged primarily
in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.
( Total: 44 Current Stock Recommendations )
Celgene Corporation   (44)
Sell Hold Buy 84%
Related companies
Sanofi-aventis Sa   (17)
Hold 47% Buy 53%
Allergan, Inc.   (30)
Hold 40% Buy 60%
Novo Nordisk A/s   (18)
Sell 17% Hold 44% Buy 39%
Amgen Inc.   (30)
Hold 47% Buy 53%
Gilead Sciences, ...   (48)
Sell Hold 15% Buy 81%
Teva Pharmaceutical ...   (41)
Hold 27% Buy 73%
Allergan Plc   (28)
Hold 29% Buy 71%
Biogen Idec Inc   (41)
Sell Hold 27% Buy 68%
Filter by Gains:   
  
Rating:
Buy CELG
up 16.15 %

Rating:
Buy CELG
up 214.51 %

Rating:
Buy CELG
down 0.46 %

Rating:
Buy CELG
up 5.75 %

Rating:
Buy CELG
up 111.31 %

Rating:
Buy CELG
up 337.55 %

Rating:
Buy CELG
up 52.94 %
Celgene Corporation (CELG) rated Buy with price target $209 by UBS
Thursday,  Feb 27, 2014  11:25 AM ET

Rating:
Buy CELG
up 111.31 %

Rating:
Buy CELG
up 51.10 %

Rating:
Sell CELG
down 33.91 %
Celgene Corporation (CELG) downgraded to Sell by Goldman
Monday,  Jan 6, 2014  8:25 AM ET

Rating:
Buy CELG
up 43.01 %

Rating:
Buy CELG
up 49.04 %

Rating:
Hold CELG
up 85.86 %
Celgene Corporation (CELG) downgraded to Neutral by Piper Jaffray
Wednesday,  Nov 27, 2013  8:25 AM ET

Rating:
Buy CELG
up 57.11 %

Rating:
Hold CELG

Your Recent Stocks
SymbolLastChange
CELG 105.93 down  -13.90 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy